On The Pen GLP-1 News

On The Pen is a leading independent news and education platform focused on GLP-1 medications, obesity medicine, and metabolic health. Through in-depth articles, podcasts, live discussions, and expert interviews, it delivers timely coverage of clinical research, FDA actions, insurance and access issues, emerging therapies, and industry developments. Designed for patients, caregivers, healthcare professionals, and anyone interested in the rapidly evolving field of obesity treatment, On The Pen combines evidence-based reporting with practical insights to help readers better understand the science, policy, and real-world impact of modern metabolic medicine.